<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Erkut E</submitter><funding>Cancer Research UK</funding><funding>Azrieli Foundation</funding><funding>Medical Research Council</funding><funding>Universität Zürich</funding><funding>National Institute for Health and Care Research</funding><funding>Heart of England NHS Foundation Trust</funding><funding>Wellcome Trust</funding><funding>Canadian Institutes of Health Research</funding><pagination>2625-2642</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12808965</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>112(11)</volume><pubmed_abstract>Syndromic cardiac malformations can result in morbidity, yet their genetic etiology is only understood for a subset of individuals. Genome sequencing efforts in congenital anomaly cohorts may identify disease-associated variants in previously unrecognized genes. Through international matchmaking efforts, we identified eighteen individuals in total with de novo or loss-of-function variants in EIF3A (n = 4) or EIF3B (n = 14). The clinical phenotype varied but predominantly included cardiac defects, craniofacial dysmorphisms, mild developmental delays, and behavioral abnormalities. These genes encode core subunits of the eukaryotic initiation factor 3 (eIF3) complex, which plays a critical role in binding mRNA transcripts to the 40S ribosomal subunit during translation initiation. Both genes </pubmed_abstract><journal>American journal of human genetics</journal><pubmed_title>A cardiovascular, craniofacial, and neurodevelopmental disorder caused by loss-of-function variants in the eIF3 complex component genes EIF3A and EIF3B.</pubmed_title><pmcid>PMC12808965</pmcid><funding_grant_id>PJT 178155</funding_grant_id><pubmed_authors>Lees H</pubmed_authors><pubmed_authors>Quelin C</pubmed_authors><pubmed_authors>Ranza E</pubmed_authors><pubmed_authors>Stuebben M</pubmed_authors><pubmed_authors>McDonald L</pubmed_authors><pubmed_authors>Jeeneea R</pubmed_authors><pubmed_authors>Koboldt DC</pubmed_authors><pubmed_authors>Dingmann B</pubmed_authors><pubmed_authors>Perrin L</pubmed_authors><pubmed_authors>Pingault V</pubmed_authors><pubmed_authors>Scott IC</pubmed_authors><pubmed_authors>Zanoni P</pubmed_authors><pubmed_authors>Schwartz MLB</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Kolokotronis K</pubmed_authors><pubmed_authors>Rauch A</pubmed_authors><pubmed_authors>Levy J</pubmed_authors><pubmed_authors>Kim RH</pubmed_authors><pubmed_authors>Kupper C</pubmed_authors><pubmed_authors>Kopps AM</pubmed_authors><pubmed_authors>Manshaei R</pubmed_authors><pubmed_authors>Leonard J</pubmed_authors><pubmed_authors>Gosselin R</pubmed_authors><pubmed_authors>Jobling RK</pubmed_authors><pubmed_authors>Littlejohn R</pubmed_authors><pubmed_authors>Dubourg C</pubmed_authors><pubmed_authors>Skraban C</pubmed_authors><pubmed_authors>Mayer D</pubmed_authors><pubmed_authors>Ding Q</pubmed_authors><pubmed_authors>Riedijk AS</pubmed_authors><pubmed_authors>Diderich KEM</pubmed_authors><pubmed_authors>Sousa S</pubmed_authors><pubmed_authors>Bedoukian EC</pubmed_authors><pubmed_authors>McLean SD</pubmed_authors><pubmed_authors>Blanc X</pubmed_authors><pubmed_authors>Escobar LF</pubmed_authors><pubmed_authors>Guillen Sacoto MJ</pubmed_authors><pubmed_authors>Pattani N</pubmed_authors><pubmed_authors>Rosmaninho-Salgado J</pubmed_authors><pubmed_authors>Moran OM</pubmed_authors><pubmed_authors>Schnurer MT</pubmed_authors><pubmed_authors>Somerville C</pubmed_authors><pubmed_authors>Conlin LK</pubmed_authors><pubmed_authors>Haag CD</pubmed_authors><pubmed_authors>Antonarakis SE</pubmed_authors><pubmed_authors>Cox H</pubmed_authors><pubmed_authors>Kenia P</pubmed_authors><pubmed_authors>Erkut E</pubmed_authors><pubmed_authors>Reichert SL</pubmed_authors><pubmed_authors>Herzig L</pubmed_authors><pubmed_authors>Elmslie F</pubmed_authors></additional><is_claimable>false</is_claimable><name>A cardiovascular, craniofacial, and neurodevelopmental disorder caused by loss-of-function variants in the eIF3 complex component genes EIF3A and EIF3B.</name><description>Syndromic cardiac malformations can result in morbidity, yet their genetic etiology is only understood for a subset of individuals. Genome sequencing efforts in congenital anomaly cohorts may identify disease-associated variants in previously unrecognized genes. Through international matchmaking efforts, we identified eighteen individuals in total with de novo or loss-of-function variants in EIF3A (n = 4) or EIF3B (n = 14). The clinical phenotype varied but predominantly included cardiac defects, craniofacial dysmorphisms, mild developmental delays, and behavioral abnormalities. These genes encode core subunits of the eukaryotic initiation factor 3 (eIF3) complex, which plays a critical role in binding mRNA transcripts to the 40S ribosomal subunit during translation initiation. Both genes </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-07-16T06:47:19.411Z</modification><creation>2026-07-09T10:42:06.129Z</creation></dates><accession>S-EPMC12808965</accession><cross_references><pubmed>41033306</pubmed><doi>10.1016/j.ajhg.2025.09.008</doi></cross_references></HashMap>